Spots Global Cancer Trial Database for letrozole 2.5mg oral tablet; ribociclib 600mg oral tablet
Every month we try and update this database with for letrozole 2.5mg oral tablet; ribociclib 600mg oral tablet cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole | NCT05163106 | Breast Cancer HER2-negative B... ER-positive Bre... Locally Advance... Luminal A Breas... Luminal B Breas... | Letrozole 2.5mg... Goserelin | 18 Years - | University Hospital, Akershus | |
Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole | NCT05163106 | Breast Cancer HER2-negative B... ER-positive Bre... Locally Advance... Luminal A Breas... Luminal B Breas... | Letrozole 2.5mg... Goserelin | 18 Years - | University Hospital, Akershus |